Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%

Follow BIIB

Alert me

Market cap: $34.8B
P/E: 41.0×
Fwd P/E: 31.5×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	38.04	19.61	19.93	12.75	+8 more quarters Free account
P/S ratio Full definition →	3.18	2.72	2.61	2.04
P/FCF ratio Full definition →	12.56	11.24	12.77	9.08
P/Operating CF Full definition →	71.09	41.81	50.37	16.14
P/B ratio Full definition →	1.69	1.45	1.41	1.13
Price to Tangible BV Full definition →	0.00	8.68	9.97	8.61
EV/Sales Full definition →	3.78	2.92	2.86	2.27
EV/EBITDA Full definition →	14.71	9.57	9.62	7.23
EV/Operating CF Full definition →	13.17	11.19	12.82	9.32
EV/FCF Full definition →	14.93	12.07	13.99	10.11
Quick Ratio Full definition →	0.81	1.88	1.54	1.62
Current Ratio Full definition →	1.87	3.06	2.68	2.72
Net Debt/EBITDA Full definition →	10.18	2.83	5.84	2.72
Debt/Assets Full definition →	22.72%	21.33%	21.35%	21.52%
Debt/Equity Full definition →	0.39	0.34	0.34	0.35
Asset Turnover Full definition →	0.33	0.35	0.34	0.35
Operating CF/Net income Full definition →	4.60	2.02	(10.47)	2.73
Capex/Depreciation Full definition →	(0.40)	(0.16)	(0.19)	(0.20)
Research and Development Expense of Revenue Full definition →	19.36%	21.75%	22.35%	17.21%
Selling, General and Administrative Expense of Revenue Full definition →	25.94%	24.51%	29.94%	23.47%
Intangible Assets out of Total Assets Full definition →	0.64	0.53	0.53	0.54
Share Based Compensation of Revenue Full definition →	2.83%	3.39%	2.61%	2.97%
Graham Net Nets Full definition →	(0.19)	(0.06)	(0.09)	(0.10)
Graham Number Full definition →	127.71	163.27	157.35	175.25
Earnings Yield Full definition →	2.63%	5.10%	5.02%	7.85%
Free Cash Flow Yield Full definition →	7.96%	8.90%	7.83%	11.02%
Revenue per Share Full definition →	18.52	16.83	15.56	17.29
Operating CF per Share Full definition →	3.04	4.39	3.49	8.68
Capex per Share Full definition →	(1.19)	(0.35)	(0.41)	(0.35)
Free Cash Flow per Share Full definition →	1.85	4.04	3.08	8.33
Cash per Share Full definition →	8.70	29.09	26.05	27.02
Shareholders Equity per Share Full definition →	127.61	126.71	124.62	124.20
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	127.61	126.71	124.62	124.20
Free Cash Flow Full definition →	273.00	594.30	451.70	1,221.00
Working Capital Full definition →	3,388.60	6,191.50	5,624.70	5,646.60
Capital Expenditures Full definition →	(175.90)	(51.20)	(60.20)	(51.50)
Net Current Asset Value Full definition →	(5,932.90)	(1,641.00)	(2,208.60)	(2,063.40)
EV/EBIT Full definition →	30.63	15.42	15.17	10.37
Capex to Sales Full definition →	0.06	0.02	0.03	0.02
Price to Operating Income Full definition →	25.78	14.36	13.85	9.31
Other line items
Average Receivables Full definition →	1,754.90	1,682.85	1,373.60	1,455.15
Average Payables Full definition →	406.15	375.00	428.10	417.90
Average Inventory Full definition →	2,329.30	2,111.45	2,314.30	2,339.30
Average Assets Full definition →	30,208.40	28,758.10	28,744.40	28,760.35
Average Common Equity Full definition →	18,241.00	17,815.20	17,486.40	17,283.20

Show all line items

Columns are period end dates

Stockrow Weekly